Gregory Y H Lip Selected Research

Gregory Y H Lip Research Topics

Disease

849	Atrial Fibrillation 11/2022 - 01/2002
557	Stroke (Strokes) 11/2022 - 01/2002
438	Hemorrhage 11/2022 - 01/2002
152	Ischemic Stroke 09/2022 - 12/2004
147	Heart Failure 09/2022 - 11/2002
127	Hypertension (High Blood Pressure) 08/2022 - 07/2002
109	Thromboembolism 01/2022 - 05/2003
106	Embolism (Embolus) 10/2022 - 09/2004
106	Myocardial Infarction 09/2022 - 11/2002
94	Thrombosis (Thrombus) 07/2022 - 01/2002
83	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 01/2002
62	Acute Coronary Syndrome 01/2022 - 12/2002
58	Inflammation (Inflammations) 01/2022 - 09/2002
48	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2003
47	Vascular Diseases (Vascular Disease) 01/2022 - 06/2004
47	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 03/2011
44	Diabetes Mellitus 11/2021 - 08/2003
41	Cardiac Arrhythmias (Arrythmia) 04/2022 - 12/2002
37	Neoplasms (Cancer) 10/2022 - 09/2002
36	Venous Thromboembolism 09/2022 - 10/2002
34	Transient Ischemic Attack 05/2021 - 06/2008
31	Chronic Renal Insufficiency 01/2022 - 02/2004
22	Atherosclerosis 01/2022 - 02/2002
22	COVID-19 01/2022 - 01/2020
21	Peripheral Arterial Disease 08/2022 - 04/2003
18	Dementia (Dementias) 01/2022 - 10/2012
17	Heart Diseases (Heart Disease) 07/2022 - 02/2004
14	Coronary Disease (Coronary Heart Disease) 07/2022 - 03/2003
14	Fibrosis (Cirrhosis) 01/2022 - 05/2003
13	Systolic Heart Failure 01/2017 - 08/2004
12	Obesity 11/2021 - 09/2006
10	Cerebral Hemorrhage 09/2022 - 09/2011
10	Body Weight (Weight, Body) 01/2022 - 09/2006
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2011
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2004
9	ST Elevation Myocardial Infarction 08/2021 - 06/2009
9	Pulmonary Embolism 12/2020 - 01/2003

Drug/Important Bio-Agent (IBA)

441	AnticoagulantsIBA 11/2022 - 10/2003
310	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 01/2002
274	Vitamin K FDA Link 10/2022 - 09/2004
143	Dabigatran FDA Link 07/2022 - 03/2010
138	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 08/2002
106	apixabanIBA 07/2022 - 09/2008
103	RivaroxabanIBA 09/2022 - 03/2007
63	N(4)-oleylcytosine arabinosideIBA 09/2022 - 11/2013
61	edoxabanIBA 10/2022 - 01/2012
61	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2004
51	von Willebrand FactorIBA 01/2018 - 07/2002
48	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 12/2003
44	Pharmaceutical PreparationsIBA 11/2022 - 01/2004
36	Clopidogrel (Plavix)FDA Link 08/2021 - 08/2002
33	P-SelectinIBA 01/2017 - 05/2002
29	omega-Chloroacetophenone (Mace)IBA 07/2022 - 02/2008
29	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2006
29	C-Reactive ProteinIBA 01/2021 - 06/2003
25	Factor Xa InhibitorsIBA 01/2022 - 03/2007
24	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013 - 02/2002
23	LipidsIBA 07/2022 - 08/2003
23	Interleukin-6 (Interleukin 6)IBA 01/2018 - 07/2003
22	CreatinineIBA 01/2022 - 02/2004
20	AntithrombinsIBA 10/2021 - 01/2005
20	E-SelectinIBA 01/2017 - 06/2003
19	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 04/2015
19	Anti-Arrhythmia AgentsIBA 01/2022 - 07/2004
18	fibrin fragment D (D-dimer)IBA 01/2021 - 01/2003
17	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 09/2004
17	Fibrinogen (Factor I)FDA Link 01/2021 - 01/2003
17	Thromboplastin (Tissue Factor)IBA 01/2019 - 09/2002
16	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2004
16	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 11/2002
15	Enoxaparin (Lovenox)FDA LinkGeneric 01/2021 - 01/2006
14	FibrinIBA 01/2018 - 07/2003
13	AcenocoumarolIBA 03/2018 - 07/2011
11	CholesterolIBA 01/2022 - 08/2003
11	TicagrelorIBA 08/2021 - 01/2012
11	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 09/2004
11	Thrombin FDA Link 01/2018 - 12/2004
11	Matrix Metalloproteinases (MMPs)IBA 01/2012 - 01/2004
10	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 01/2003
10	Angiotensin Receptor AntagonistsIBA 10/2020 - 11/2002
10	AngiopoietinsIBA 08/2009 - 02/2004
9	idraparinuxIBA 01/2018 - 07/2011
9	angiogeninIBA 08/2013 - 12/2007
9	Tissue Inhibitor of Metalloproteinase-1IBA 01/2012 - 05/2003
9	CD40 Ligand (CD40L)IBA 08/2011 - 06/2004
8	DiureticsIBA 01/2022 - 09/2003
8	Dronedarone FDA Link 01/2022 - 05/2009
8	Digoxin (Digitek)FDA LinkGeneric 01/2022 - 12/2007

Therapy/Procedure

486	Therapeutics 11/2022 - 01/2002
81	Percutaneous Coronary Intervention 07/2022 - 12/2002
47	Electric Countershock (Cardioversion) 04/2022 - 08/2004
43	Stents 07/2022 - 02/2008
41	Secondary Prevention 04/2022 - 05/2003
40	Catheter Ablation 07/2022 - 12/2009
23	Drug Therapy (Chemotherapy) 11/2022 - 10/2003
16	Patient Readmission 01/2022 - 05/2011
10	Cardiac Rehabilitation 01/2022 - 09/2003
9	Defibrillators (Defibrillator) 01/2021 - 09/2009
9	Contraindications 10/2016 - 11/2002
8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 05/2008